555 related articles for article (PubMed ID: 25973038)
1. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
[TBL] [Abstract][Full Text] [Related]
2. Proteomic identification of alpha-2-HS-glycoprotein as a plasma biomarker of hypopharyngeal squamous cell carcinoma.
Tian WD; Li JZ; Hu SW; Peng XW; Li G; Liu X; Chen HH; Xu X; Li XP
Int J Clin Exp Pathol; 2015; 8(8):9021-31. PubMed ID: 26464644
[TBL] [Abstract][Full Text] [Related]
3. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
[TBL] [Abstract][Full Text] [Related]
4. Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.
Zhang J; Wang K; Zhang J; Liu SS; Dai L; Zhang JY
J Proteome Res; 2011 Jun; 10(6):2863-72. PubMed ID: 21517111
[TBL] [Abstract][Full Text] [Related]
5. Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study.
Fan NJ; Gao CF; Wang XL
OMICS; 2013 Apr; 17(4):215-23. PubMed ID: 23496306
[TBL] [Abstract][Full Text] [Related]
6. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
[TBL] [Abstract][Full Text] [Related]
7. Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis.
Zhu X; Ding M; Yu ML; Feng MX; Tan LJ; Zhao FK
BMC Cancer; 2010 Jun; 10():290. PubMed ID: 20546628
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma].
Chen J; Wu W; Chen L; Ma X; Zhao Y; Zhou H; Yang R; Hu L
Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(28):2175-9. PubMed ID: 25331466
[TBL] [Abstract][Full Text] [Related]
9. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of blood level of proteins before and after operation in patients with esophageal squamous cell carcinoma at high-incidence area in Henan Province.
An JY; Fan ZM; Zhuang ZH; Qin YR; Gao SS; Li JL; Wang LD
World J Gastroenterol; 2004 Nov; 10(22):3365-8. PubMed ID: 15484320
[TBL] [Abstract][Full Text] [Related]
12. Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.
Jia K; Li W; Wang F; Qu H; Qiao Y; Zhou L; Sun Y; Ma Q; Zhao X
Oncotarget; 2016 Apr; 7(17):23569-80. PubMed ID: 26993605
[TBL] [Abstract][Full Text] [Related]
13. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches.
Zhang LY; Ying WT; Mao YS; He HZ; Liu Y; Wang HX; Liu F; Wang K; Zhang DC; Wang Y; Wu M; Qian XH; Zhao XH
World J Gastroenterol; 2003 Apr; 9(4):650-4. PubMed ID: 12679903
[TBL] [Abstract][Full Text] [Related]
14. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.
Kitamura Y; Usami R; Ichihara S; Kida H; Satoh M; Tomimoto H; Murata M; Oikawa S
Neurol Res; 2017 Mar; 39(3):231-238. PubMed ID: 28107809
[TBL] [Abstract][Full Text] [Related]
15. Proteomics-based identification of plasma biomarkers in oral squamous cell carcinoma.
Tung CL; Lin ST; Chou HC; Chen YW; Lin HC; Tung CL; Huang KJ; Chen YJ; Lee YR; Chan HL
J Pharm Biomed Anal; 2013 Mar; 75():7-17. PubMed ID: 23312379
[TBL] [Abstract][Full Text] [Related]
16. [Serum proteomic spectra of esophageal squamous cell carcinoma patients analyzed with IMAC3 protein chip].
Liu CZ; Zhu PY; Shi MX; Liu JB; Liao P; Xiang CQ; Zhang YX; Wang WJ
Ai Zheng; 2008 Mar; 27(3):272-8. PubMed ID: 18334116
[TBL] [Abstract][Full Text] [Related]
17. Proteomic identification of plasma biomarkers in uterine leiomyoma.
Lin CP; Chen YW; Liu WH; Chou HC; Chang YP; Lin ST; Li JM; Jian SF; Lee YR; Chan HL
Mol Biosyst; 2012 Apr; 8(4):1136-45. PubMed ID: 22193648
[TBL] [Abstract][Full Text] [Related]
18. Utility of serum peptidome patterns of esophageal squamous cell carcinoma patients for comprehensive treatment.
Wan QL; Hou XS; Zhao G
Asian Pac J Cancer Prev; 2013; 14(5):2919-23. PubMed ID: 23803054
[TBL] [Abstract][Full Text] [Related]
19. iTRAQ-based quantitative proteomic analysis of esophageal squamous cell carcinoma.
Deng F; Zhou K; Li Q; Liu D; Li M; Wang H; Zhang W; Ma Y
Tumour Biol; 2016 Feb; 37(2):1909-18. PubMed ID: 26330293
[TBL] [Abstract][Full Text] [Related]
20. Under-expression of annexin A2 is associated with Kazakh's esophageal squamous cell carcinoma.
Li X; Zheng S; Liu Q; Liu T; Liang M; Gao X; Lu M; Sheyhidin I; Lu X
Mol Carcinog; 2015 Sep; 54(9):779-88. PubMed ID: 24668792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
